Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The cancer specific advance directive

S R Berry1, P A Singer

  • 1University of Toronto Joint Centre for Bioethics, and Department of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Ontario, Canada.

Cancer
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness analysis of selective first-line use of biologics for unresectable <i>RAS</i> wild-type left-sided metastatic colorectal cancer.

Current oncology (Toronto, Ont.)·2019
Same author

Cancer care in South India: perspectives from visiting Canadian oncologists.

Current oncology (Toronto, Ont.)·2017
Same author

Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Clinical ethicists' perspectives on organisational ethics in healthcare organisations.

Journal of medical ethics·2008
Same author

Bidil: recontextualizing the race debate.

The pharmacogenomics journal·2008
Same author

Applying genomics-related technologies for Africa's health needs.

African journal of medicine and medical sciences·2007

A new cancer-specific advance directive was developed and found more acceptable by oncology outpatients than a generic version. This disease-specific document better addresses the unique needs of cancer patients during end-of-life care.

Area of Science:

  • Oncology
  • Palliative Care
  • Bioethics

Background:

  • Current advance directives inadequately address the specific needs of cancer patients.
  • End-of-life care planning is crucial for cancer patients.

Purpose of the Study:

  • To develop a cancer-specific advance directive.
  • To compare patient acceptance of a cancer-specific versus a generic advance directive.
  • To describe oncology patient preferences for life-sustaining treatments.

Main Methods:

  • A cancer-specific advance directive was developed through literature review, interviews, focus groups, and validity testing.
  • 91 oncology outpatients received both a cancer-specific and a generic advance directive.
  • Patient preference for the advance directive was assessed, and treatment preferences were recorded.

Related Experiment Videos

Main Results:

  • Of 60 respondents, 50 expressed a preference.
  • 32 patients (64%) preferred the cancer-specific directive, citing its specificity and relevance.
  • 18 patients (36%) preferred the generic directive.

Conclusions:

  • A cancer-specific advance directive has been developed and evaluated.
  • The developed directive is recommended for clinical use with cancer patients.
  • This tool enhances end-of-life care planning for individuals with cancer.